362 related articles for article (PubMed ID: 19075045)
1. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.
Krishna G; Moton A; Ma L; Medlock MM; McLeod J
Antimicrob Agents Chemother; 2009 Mar; 53(3):958-66. PubMed ID: 19075045
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.
Walravens J; Brouwers J; Spriet I; Tack J; Annaert P; Augustijns P
Clin Pharmacokinet; 2011 Nov; 50(11):725-34. PubMed ID: 21973269
[TBL] [Abstract][Full Text] [Related]
3. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
Lin TY; Yang MH; Chang FY
Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
[TBL] [Abstract][Full Text] [Related]
4. Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.
Krishna G; Ma L; Martinho M; O'Mara E
Antimicrob Agents Chemother; 2012 Aug; 56(8):4196-201. PubMed ID: 22615291
[TBL] [Abstract][Full Text] [Related]
5. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.
Kraft WK; Chang PS; van Iersel ML; Waskin H; Krishna G; Kersemaekers WM
Antimicrob Agents Chemother; 2014 Jul; 58(7):4020-5. PubMed ID: 24798274
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
7. Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers.
Sansone-Parsons A; Krishna G; Calzetta A; Wexler D; Kantesaria B; Rosenberg MA; Saltzman MA
Antimicrob Agents Chemother; 2006 May; 50(5):1881-3. PubMed ID: 16641468
[TBL] [Abstract][Full Text] [Related]
8. What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
Pea F; Furlanut M; Viale P
Antimicrob Agents Chemother; 2009 Aug; 53(8):3608-9; author reply 609-10. PubMed ID: 19617468
[No Abstract] [Full Text] [Related]
9. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.
Courtney R; Wexler D; Radwanski E; Lim J; Laughlin M
Br J Clin Pharmacol; 2004 Feb; 57(2):218-22. PubMed ID: 14748822
[TBL] [Abstract][Full Text] [Related]
10. Effect of a high-fat meal on the pharmacokinetics of 300-milligram posaconazole in a solid oral tablet formulation.
Kersemaekers WM; Dogterom P; Xu J; Marcantonio EE; de Greef R; Waskin H; van Iersel ML
Antimicrob Agents Chemother; 2015; 59(6):3385-9. PubMed ID: 25824210
[TBL] [Abstract][Full Text] [Related]
11. Effect of varying amounts of a liquid nutritional supplement on the pharmacokinetics of posaconazole in healthy volunteers.
Krishna G; Ma L; Vickery D; Yu X; Wu I; Power E; Beresford E; Komjathy S
Antimicrob Agents Chemother; 2009 Nov; 53(11):4749-52. PubMed ID: 19738015
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of posaconazole administered orally or by nasogastric tube in healthy volunteers.
Dodds Ashley ES; Varkey JB; Krishna G; Vickery D; Ma L; Yu X; Malavade D; Goodwin M; Perfect JR; Power E
Antimicrob Agents Chemother; 2009 Jul; 53(7):2960-4. PubMed ID: 19433558
[TBL] [Abstract][Full Text] [Related]
13. Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.
Krishna G; Sansone-Parsons A; Kantesaria B
Curr Med Res Opin; 2007 Jun; 23(6):1415-22. PubMed ID: 17559737
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pharmacokinetics of posaconazole and rifabutin following co-administration to healthy men.
Krishna G; Parsons A; Kantesaria B; Mant T
Curr Med Res Opin; 2007 Mar; 23(3):545-52. PubMed ID: 17355736
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.
Gubbins PO; Krishna G; Sansone-Parsons A; Penzak SR; Dong L; Martinho M; Anaissie EJ
Antimicrob Agents Chemother; 2006 Jun; 50(6):1993-9. PubMed ID: 16723557
[TBL] [Abstract][Full Text] [Related]
16. The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.
Junghard O; Hassan-Alin M; Hasselgren G
Eur J Clin Pharmacol; 2002 Oct; 58(7):453-8. PubMed ID: 12389067
[TBL] [Abstract][Full Text] [Related]
17. Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers.
Wang Y; Zhang H; Meng L; Wang M; Yuan H; Ou N; Zhang H; Li Z; Shi R
Eur J Clin Pharmacol; 2010 Jun; 66(6):563-9. PubMed ID: 20414645
[TBL] [Abstract][Full Text] [Related]
18. A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers.
Krishna G; Ma L; Martinho M; Preston RA; O'Mara E
J Antimicrob Chemother; 2012 Nov; 67(11):2725-30. PubMed ID: 22833639
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography-mass spectrometry method for the quantification of posaconazole in human plasma: application to pharmacokinetics following single-dose administration in the fasted state and with a high-fat meal.
Xu HR; Chu NN; Chen WL; Wang ZD; Li XN
Pharmazie; 2013 Mar; 68(3):173-7. PubMed ID: 23556334
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
